Cargando…

The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center

BACKGROUND: The 2018 International Federation of Gynecology and Obstetrics (FIGO) staging guideline for cervical cancer includes stage IIIC recognized by preoperative radiology (IIIC-r) to state there are lymph nodes metastases (LNM) identified by imaging tools. We aim to explore the reasonability a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, E, Huang, Shuying, Ran, Xuting, Huang, Yue, Li, Zhengyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912513/
https://www.ncbi.nlm.nih.gov/pubmed/33639874
http://dx.doi.org/10.1186/s12885-021-07890-w
_version_ 1783656594071879680
author Yang, E
Huang, Shuying
Ran, Xuting
Huang, Yue
Li, Zhengyu
author_facet Yang, E
Huang, Shuying
Ran, Xuting
Huang, Yue
Li, Zhengyu
author_sort Yang, E
collection PubMed
description BACKGROUND: The 2018 International Federation of Gynecology and Obstetrics (FIGO) staging guideline for cervical cancer includes stage IIIC recognized by preoperative radiology (IIIC-r) to state there are lymph nodes metastases (LNM) identified by imaging tools. We aim to explore the reasonability and limitations of stage IIIC-r and try to explore the potential reasons. METHODS: Electronic medical records were used to identify patients with cervical cancer. According to the new staging guidelines, patients were reclassified and assigned into five cohorts: stage I, stage II, stage IIIC-r, LNM confirmed by pathology (IIIC-p) and LNM detected by radiology and confirmed by pathology (IIIC r + p). Five-year overall survivals were estimated for each cohort. The diagnosis accuracy of computed tomography (CT), magnetic resonance imaging (MRI) and diameter of detected lymph nodes were also evaluated. RESULTS: A total of 619 patients were identified. The mean follow-up months were 65 months (95% CI 64.43–65.77) for all patients. By comparison, the 5-year overall survival rates were not statistically different (p = 0.21) among stage IIIC-r, stage I and stage II. While, the rates were both statistical different (p<0.001) among stage IIIC-p, IIIC r + p and stage I and stage II. The sensitivities of CT and MRI in detecting LNM preoperatively were 51.2 and 48.8%. The mean maximum diameter of pelvic lymph nodes detected by CT cohort was 1.2 cm in IIIC-r cohort, and was 1.3 cm in IIIC r + p cohort. While, the mean maximum diameter of pelvic lymph nodes detected by MRI was 1.2 cm in IIIC-r cohort, and was 1.48 cm in IIIC r + p cohort. When the diagnosis efficacy of the diameter of pelvic lymph nodes in detecting LNM were evaluated, the area under the receiver operating characteristic curve (ROC curve) was 0.58 (p = 0.05). CONCLUSIONS: It seems that the FIGO 2018 staging guideline for cervical cancer is likely to has certain limitations for the classification of those with LNM. CT or MRI, however, has limitations on detecting LNM. It would be better to use more accurate imaging tools to identify LNM in the clinical practices.
format Online
Article
Text
id pubmed-7912513
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79125132021-03-02 The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center Yang, E Huang, Shuying Ran, Xuting Huang, Yue Li, Zhengyu BMC Cancer Research Article BACKGROUND: The 2018 International Federation of Gynecology and Obstetrics (FIGO) staging guideline for cervical cancer includes stage IIIC recognized by preoperative radiology (IIIC-r) to state there are lymph nodes metastases (LNM) identified by imaging tools. We aim to explore the reasonability and limitations of stage IIIC-r and try to explore the potential reasons. METHODS: Electronic medical records were used to identify patients with cervical cancer. According to the new staging guidelines, patients were reclassified and assigned into five cohorts: stage I, stage II, stage IIIC-r, LNM confirmed by pathology (IIIC-p) and LNM detected by radiology and confirmed by pathology (IIIC r + p). Five-year overall survivals were estimated for each cohort. The diagnosis accuracy of computed tomography (CT), magnetic resonance imaging (MRI) and diameter of detected lymph nodes were also evaluated. RESULTS: A total of 619 patients were identified. The mean follow-up months were 65 months (95% CI 64.43–65.77) for all patients. By comparison, the 5-year overall survival rates were not statistically different (p = 0.21) among stage IIIC-r, stage I and stage II. While, the rates were both statistical different (p<0.001) among stage IIIC-p, IIIC r + p and stage I and stage II. The sensitivities of CT and MRI in detecting LNM preoperatively were 51.2 and 48.8%. The mean maximum diameter of pelvic lymph nodes detected by CT cohort was 1.2 cm in IIIC-r cohort, and was 1.3 cm in IIIC r + p cohort. While, the mean maximum diameter of pelvic lymph nodes detected by MRI was 1.2 cm in IIIC-r cohort, and was 1.48 cm in IIIC r + p cohort. When the diagnosis efficacy of the diameter of pelvic lymph nodes in detecting LNM were evaluated, the area under the receiver operating characteristic curve (ROC curve) was 0.58 (p = 0.05). CONCLUSIONS: It seems that the FIGO 2018 staging guideline for cervical cancer is likely to has certain limitations for the classification of those with LNM. CT or MRI, however, has limitations on detecting LNM. It would be better to use more accurate imaging tools to identify LNM in the clinical practices. BioMed Central 2021-02-27 /pmc/articles/PMC7912513/ /pubmed/33639874 http://dx.doi.org/10.1186/s12885-021-07890-w Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Yang, E
Huang, Shuying
Ran, Xuting
Huang, Yue
Li, Zhengyu
The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center
title The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center
title_full The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center
title_fullStr The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center
title_full_unstemmed The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center
title_short The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center
title_sort 5-year overall survival of cervical cancer in stage iiic-r was little different to stage i and ii: a retrospective analysis from a single center
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912513/
https://www.ncbi.nlm.nih.gov/pubmed/33639874
http://dx.doi.org/10.1186/s12885-021-07890-w
work_keys_str_mv AT yange the5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter
AT huangshuying the5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter
AT ranxuting the5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter
AT huangyue the5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter
AT lizhengyu the5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter
AT yange 5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter
AT huangshuying 5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter
AT ranxuting 5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter
AT huangyue 5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter
AT lizhengyu 5yearoverallsurvivalofcervicalcancerinstageiiicrwaslittledifferenttostageiandiiaretrospectiveanalysisfromasinglecenter